Prospects of primary ovarian insufficiency patient-specific pluripotent stem cells for disease modeling and clinical impacts

Hsin Fu Chen, Hong Nerng Ho

Research output: Contribution to journalReview article

Abstract

Background: Primary ovarian insufficiency (POI) or premature ovarian failure (POF) is defined by spontaneous amenorrhea with elevated serum gonadotropin levels and reduced estradiol level. POI frequently leads to reduced fertility and a number of clinical symptoms or signs related to premature menopause. The etiologies of POI include genetic or chromosomal defects, autoimmune factors, environmental factors, and idiopathic causes. However, the pathogenesis of POI is difficult to study due to a lack of suitable disease models. Recent evidence suggests that pluripotent stem cells (PSCs), including embryonic stem (ES) cells and induced pluripotent stem (iPS) cells, can be induced into germ cells and granulosa cells. Specifically, mouse PSCs can be directed to functional sperm and oocytes that lead to viable and fertile offspring. However, in humans, only early germ cells have been derived, including female primordial germ cells and immature haploid male germ cells with meiotic potential. Some evidence also suggests defective differentiation potential into germ cells and granulosa cells from POI patient-specific iPS cells (by reprogramming somatic cells from POI patients). Objective and Results: This report reviews current studies, advances, and future prospects in the derivation of POI patient-specific iPS cells, the efficiency of differentiating iPS cells into functional and mature germ cells and granulosa cells, and the potential to use the entire process as a disease model to screen drugs, toxicants and toxins. Conclusion: It is concluded that current data have provided good evidence to support the use of POI patient-specific iPS cells to model human POI and potentially other reproductive disorders.

Original languageEnglish
Pages (from-to)67-80
Number of pages14
JournalCurrent Women's Health Reviews
Volume14
Issue number1
DOIs
Publication statusPublished - Mar 1 2018

Fingerprint

Primary Ovarian Insufficiency
Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Germ Cells
Granulosa Cells
Premature Menopause
Haploidy
Amenorrhea
Embryonic Stem Cells
Gonadotropins
Signs and Symptoms
Oocytes
Fertility
Spermatozoa
Estradiol

Keywords

  • Embryonic stem cells
  • Germ cells
  • Granulosa cells
  • Induced pluripotent stem cells
  • Oocytes
  • Premature ovarian failure
  • Primary ovarian insufficiency
  • Sperm

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Prospects of primary ovarian insufficiency patient-specific pluripotent stem cells for disease modeling and clinical impacts. / Chen, Hsin Fu; Ho, Hong Nerng.

In: Current Women's Health Reviews, Vol. 14, No. 1, 01.03.2018, p. 67-80.

Research output: Contribution to journalReview article

@article{8787f1d087d942a2a540bcb20d400bfa,
title = "Prospects of primary ovarian insufficiency patient-specific pluripotent stem cells for disease modeling and clinical impacts",
abstract = "Background: Primary ovarian insufficiency (POI) or premature ovarian failure (POF) is defined by spontaneous amenorrhea with elevated serum gonadotropin levels and reduced estradiol level. POI frequently leads to reduced fertility and a number of clinical symptoms or signs related to premature menopause. The etiologies of POI include genetic or chromosomal defects, autoimmune factors, environmental factors, and idiopathic causes. However, the pathogenesis of POI is difficult to study due to a lack of suitable disease models. Recent evidence suggests that pluripotent stem cells (PSCs), including embryonic stem (ES) cells and induced pluripotent stem (iPS) cells, can be induced into germ cells and granulosa cells. Specifically, mouse PSCs can be directed to functional sperm and oocytes that lead to viable and fertile offspring. However, in humans, only early germ cells have been derived, including female primordial germ cells and immature haploid male germ cells with meiotic potential. Some evidence also suggests defective differentiation potential into germ cells and granulosa cells from POI patient-specific iPS cells (by reprogramming somatic cells from POI patients). Objective and Results: This report reviews current studies, advances, and future prospects in the derivation of POI patient-specific iPS cells, the efficiency of differentiating iPS cells into functional and mature germ cells and granulosa cells, and the potential to use the entire process as a disease model to screen drugs, toxicants and toxins. Conclusion: It is concluded that current data have provided good evidence to support the use of POI patient-specific iPS cells to model human POI and potentially other reproductive disorders.",
keywords = "Embryonic stem cells, Germ cells, Granulosa cells, Induced pluripotent stem cells, Oocytes, Premature ovarian failure, Primary ovarian insufficiency, Sperm",
author = "Chen, {Hsin Fu} and Ho, {Hong Nerng}",
year = "2018",
month = "3",
day = "1",
doi = "10.2174/1573404813666170929121848",
language = "English",
volume = "14",
pages = "67--80",
journal = "Current Women's Health Reviews",
issn = "1573-4048",
publisher = "Bentham Science Publishers B.V.",
number = "1",

}

TY - JOUR

T1 - Prospects of primary ovarian insufficiency patient-specific pluripotent stem cells for disease modeling and clinical impacts

AU - Chen, Hsin Fu

AU - Ho, Hong Nerng

PY - 2018/3/1

Y1 - 2018/3/1

N2 - Background: Primary ovarian insufficiency (POI) or premature ovarian failure (POF) is defined by spontaneous amenorrhea with elevated serum gonadotropin levels and reduced estradiol level. POI frequently leads to reduced fertility and a number of clinical symptoms or signs related to premature menopause. The etiologies of POI include genetic or chromosomal defects, autoimmune factors, environmental factors, and idiopathic causes. However, the pathogenesis of POI is difficult to study due to a lack of suitable disease models. Recent evidence suggests that pluripotent stem cells (PSCs), including embryonic stem (ES) cells and induced pluripotent stem (iPS) cells, can be induced into germ cells and granulosa cells. Specifically, mouse PSCs can be directed to functional sperm and oocytes that lead to viable and fertile offspring. However, in humans, only early germ cells have been derived, including female primordial germ cells and immature haploid male germ cells with meiotic potential. Some evidence also suggests defective differentiation potential into germ cells and granulosa cells from POI patient-specific iPS cells (by reprogramming somatic cells from POI patients). Objective and Results: This report reviews current studies, advances, and future prospects in the derivation of POI patient-specific iPS cells, the efficiency of differentiating iPS cells into functional and mature germ cells and granulosa cells, and the potential to use the entire process as a disease model to screen drugs, toxicants and toxins. Conclusion: It is concluded that current data have provided good evidence to support the use of POI patient-specific iPS cells to model human POI and potentially other reproductive disorders.

AB - Background: Primary ovarian insufficiency (POI) or premature ovarian failure (POF) is defined by spontaneous amenorrhea with elevated serum gonadotropin levels and reduced estradiol level. POI frequently leads to reduced fertility and a number of clinical symptoms or signs related to premature menopause. The etiologies of POI include genetic or chromosomal defects, autoimmune factors, environmental factors, and idiopathic causes. However, the pathogenesis of POI is difficult to study due to a lack of suitable disease models. Recent evidence suggests that pluripotent stem cells (PSCs), including embryonic stem (ES) cells and induced pluripotent stem (iPS) cells, can be induced into germ cells and granulosa cells. Specifically, mouse PSCs can be directed to functional sperm and oocytes that lead to viable and fertile offspring. However, in humans, only early germ cells have been derived, including female primordial germ cells and immature haploid male germ cells with meiotic potential. Some evidence also suggests defective differentiation potential into germ cells and granulosa cells from POI patient-specific iPS cells (by reprogramming somatic cells from POI patients). Objective and Results: This report reviews current studies, advances, and future prospects in the derivation of POI patient-specific iPS cells, the efficiency of differentiating iPS cells into functional and mature germ cells and granulosa cells, and the potential to use the entire process as a disease model to screen drugs, toxicants and toxins. Conclusion: It is concluded that current data have provided good evidence to support the use of POI patient-specific iPS cells to model human POI and potentially other reproductive disorders.

KW - Embryonic stem cells

KW - Germ cells

KW - Granulosa cells

KW - Induced pluripotent stem cells

KW - Oocytes

KW - Premature ovarian failure

KW - Primary ovarian insufficiency

KW - Sperm

UR - http://www.scopus.com/inward/record.url?scp=85042801035&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042801035&partnerID=8YFLogxK

U2 - 10.2174/1573404813666170929121848

DO - 10.2174/1573404813666170929121848

M3 - Review article

VL - 14

SP - 67

EP - 80

JO - Current Women's Health Reviews

JF - Current Women's Health Reviews

SN - 1573-4048

IS - 1

ER -